COMP <GO>
NSC vs TMO // GROSS PROFIT MARGIN
Norfolk Southern Corporation (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: NSC 9
— TMO 5
■ METRIC PARITY
LAST: $342.64 (+0.13%) • MKT CAP: $76.86B
gross-margins
41.00%
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
gross-margins
41.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NSC VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NSC | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | 41.00% | 41.00% | 0.00 | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 13.00% | 9.30% | +3.70 | NSC | /roic <GO> |
| EV/EBITDA & P/E Valuation | 14.1x | 30.4x | -16.30 | NSC | /valuation <GO> |
| Free Cash Flow Yield | 2.81% | 2.40% | +0.41 | NSC | /fcf-yield <GO> |
| Operating Margin | 35.80% | 17.40% | +18.40 | NSC | /operating-margins <GO> |
| Net Profit Margin | 23.60% | 15.10% | +8.50 | NSC | /net-margins <GO> |
| Revenue Growth (YoY) | 0.50% | 3.90% | -3.40 | TMO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.58% | 0.24% | +1.34 | NSC | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.53 | 4.50 | -1.97 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.80% | 6.70% | +0.10 | TMO | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 67.1 | 59.1 | +7.95 | NSC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.96 | 0.94 | +0.02 | NSC | /macro-sensitivity <GO> |
| Forward P/E Multiple | 24.9x | 36.3x | -11.40 | NSC | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $76.86B | $262.22B | -$185.36B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NSC REV | TMO REV | NSC GROSS % | TMO GROSS % | NSC FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $12.18B | $44.56B | 44.0% | 44.0% | $2.16B | $6.29B |
| FY 2024 | $12.12B | $42.88B | 44.0% | 44.0% | $1.67B | $7.27B |
| FY 2023 | $12.16B | $42.86B | 44.0% | 44.0% | $2.63B | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NSC // BETA 0.96
TMO // BETA 0.94